ATE335470T1 - Identifizierung von genen, die in multiplem myelom geändert sind - Google Patents
Identifizierung von genen, die in multiplem myelom geändert sindInfo
- Publication number
- ATE335470T1 ATE335470T1 AT97927802T AT97927802T ATE335470T1 AT E335470 T1 ATE335470 T1 AT E335470T1 AT 97927802 T AT97927802 T AT 97927802T AT 97927802 T AT97927802 T AT 97927802T AT E335470 T1 ATE335470 T1 AT E335470T1
- Authority
- AT
- Austria
- Prior art keywords
- chromosome
- multiple myeloma
- determining
- chromosomal breakpoint
- subject suffering
- Prior art date
Links
- 208000034578 Multiple myelomas Diseases 0.000 title abstract 4
- 206010035226 Plasma cell myeloma Diseases 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 210000000349 chromosome Anatomy 0.000 abstract 6
- 230000002759 chromosomal effect Effects 0.000 abstract 4
- 239000000523 sample Substances 0.000 abstract 4
- 239000007850 fluorescent dye Substances 0.000 abstract 3
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 abstract 2
- 239000012634 fragment Substances 0.000 abstract 2
- 238000009396 hybridization Methods 0.000 abstract 1
- 230000031864 metaphase Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/654,482 US6245562B1 (en) | 1996-05-28 | 1996-05-28 | Identification of genes altered in multiple myeloma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE335470T1 true ATE335470T1 (de) | 2006-09-15 |
Family
ID=24625029
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97927802T ATE335470T1 (de) | 1996-05-28 | 1997-05-28 | Identifizierung von genen, die in multiplem myelom geändert sind |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US6245562B1 (de) |
| EP (2) | EP0920305B1 (de) |
| JP (1) | JP2000512133A (de) |
| AT (1) | ATE335470T1 (de) |
| AU (1) | AU711851B2 (de) |
| CA (1) | CA2256455A1 (de) |
| DE (1) | DE69736476T2 (de) |
| DK (1) | DK0920305T3 (de) |
| WO (1) | WO1997045106A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030194702A1 (en) * | 2000-12-22 | 2003-10-16 | Engelhard Eric K. | Novel compositions and methods for cancer |
| PE20210109A1 (es) | 2018-03-02 | 2021-01-19 | Ionis Pharmaceuticals Inc | Moduladores de la expresion de irf4 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5891666A (en) * | 1995-04-14 | 1999-04-06 | Amgen Canada Inc. | Genes encoding LSIRF polypeptides |
-
1996
- 1996-05-28 US US08/654,482 patent/US6245562B1/en not_active Expired - Lifetime
-
1997
- 1997-05-28 JP JP09542903A patent/JP2000512133A/ja active Pending
- 1997-05-28 WO PCT/US1997/009065 patent/WO1997045106A1/en active IP Right Grant
- 1997-05-28 EP EP97927802A patent/EP0920305B1/de not_active Expired - Lifetime
- 1997-05-28 DK DK97927802T patent/DK0920305T3/da active
- 1997-05-28 AT AT97927802T patent/ATE335470T1/de not_active IP Right Cessation
- 1997-05-28 DE DE69736476T patent/DE69736476T2/de not_active Expired - Lifetime
- 1997-05-28 CA CA002256455A patent/CA2256455A1/en not_active Abandoned
- 1997-05-28 AU AU32173/97A patent/AU711851B2/en not_active Ceased
- 1997-05-28 EP EP06016570A patent/EP1731144A1/de not_active Withdrawn
-
2000
- 2000-06-01 US US09/585,023 patent/US6958386B1/en not_active Expired - Fee Related
-
2005
- 2005-10-20 US US11/254,841 patent/US20070141579A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997045106A1 (en) | 1997-12-04 |
| EP0920305A1 (de) | 1999-06-09 |
| DE69736476T2 (de) | 2007-05-16 |
| US6245562B1 (en) | 2001-06-12 |
| EP0920305A4 (de) | 2004-12-29 |
| JP2000512133A (ja) | 2000-09-19 |
| AU711851B2 (en) | 1999-10-21 |
| EP0920305B1 (de) | 2006-08-09 |
| EP1731144A1 (de) | 2006-12-13 |
| DE69736476D1 (de) | 2006-09-21 |
| US6958386B1 (en) | 2005-10-25 |
| US20070141579A1 (en) | 2007-06-21 |
| AU3217397A (en) | 1998-01-05 |
| DK0920305T3 (da) | 2006-12-11 |
| CA2256455A1 (en) | 1997-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3612092B2 (ja) | Ｄｎａの分離・分取法及びその解析法 | |
| CA2223061C (en) | Method of and apparatus for diagnostic dna testing | |
| Khan et al. | Cost‐effective molecular inversion probe‐based ABCA4 sequencing reveals deep‐intronic variants in Stargardt disease | |
| DE1073770T1 (de) | Neuartiges Verfahren zur Identifizierung von Klonen mit einer gewünschten Biologischen Eigenschaft, ausgehend von einer Expressionsgenbank (2001/06) | |
| DK0935674T3 (da) | Fremgangsmåde til positionering af kloner ved hjælp af molekylær trimning | |
| BR9407712A (pt) | Métodos e composiçoes para sequenciamento eficaz de ácidos nuclêicos | |
| CA2218476A1 (en) | Diagnostic method | |
| ATE247718T1 (de) | Erkennung einer genetischen prädisposition fur osteoporose | |
| ATE328115T1 (de) | Multiplex genotypisierung unter verwendung von fluoreszenzmarkierten hybridisierungssonden | |
| DE60045796D1 (de) | Gesamt-chromosom analyse von protein-dns wechselwirkungen | |
| DE69210588D1 (de) | Molekulare genetische Identifikation unter Verwendung von Sonden, die polymorphe Orte erkennen | |
| ATE335086T1 (de) | Künstliche chromosomen, die die genetische information für die bildung von rekombinantem virus enthalten | |
| WO1999028506A3 (en) | Cancer susceptibility mutations of brca2 | |
| ATE207967T1 (de) | Verfahren zum screening für die erkrankung crohn durch die verwendung von tnf-mikrosatelliten allelen | |
| WO1999016780A3 (en) | Genetic sequences, diagnostic and/or quantification methods for the identification of staphylococci strains | |
| WO2005027710A3 (en) | Methods for identifying subjects at risk of melanoma and treatments thereof | |
| DE69736476D1 (de) | Identifizierung von genen, die in multiplem myelom geändert sind | |
| Pena et al. | Automated genotyping of a highly informative panel of 40 short insertion-deletion polymorphisms resolved in polyacrylamide gels for forensic identification and kinship analysis | |
| Riahi et al. | High-resolution melting (HRM) assay for the detection of recurrent BRCA1/BRCA2 germline mutations in Tunisian breast/ovarian cancer families | |
| GB2295228A (en) | Selective amplification of DNA having a plurality of sites for a specific endonuclease | |
| Telmer et al. | Detection and assignment of TP53 mutations in tumor DNA using peptide mass signature genotyping | |
| US20080044916A1 (en) | Computational selection of probes for localizing chromosome breakpoints | |
| WO1999002735A3 (en) | Diagnostic assays and kits for body mass and cardiovascular disorders | |
| Scouras et al. | The β− tubulin genes of Drosophila auraria are arranged in a cluster | |
| Hampe et al. | Oligonucleotide fingerprinting as a means to identify and survey long-term cultured B cell hybridomas and T cell lines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |